Dataset Information

Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.

ABSTRACT: A series of potent macrocyclic HIV-1 protease inhibitors have been designed and synthesized. The compounds incorporated 16- to 19-membered macrocyclic rings between a nelfinavir-like P2 ligand and a tyrosine side chain containing a hydroxyethylamine sulfonamide isostere. All cyclic inhibitors are more potent than their corresponding acyclic counterparts. Saturated derivatives showed slight reduction of potency compared to the respective unsaturated derivatives. Compound containing a 16-membered ring as the P1-P2 ligand showed the most potent enzyme inhibitory and antiviral activity.

SUBMITTER: Ghosh AK

PROVIDER: S-EPMC4133278 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.

Ghosh Arun K AK Schiltz Gary E GE Rusere Linah N LN Osswald Heather L HL Walters D Eric DE Amano Masayuki M Mitsuya Hiroaki H

Organic & biomolecular chemistry 20140901 35

A series of potent macrocyclic HIV-1 protease inhibitors have been designed and synthesized. The compounds incorporated 16- to 19-membered macrocyclic rings between a nelfinavir-like P2 ligand and a tyrosine side chain containing a hydroxyethylamine sulfonamide isostere. All cyclic inhibitors are more potent than their corresponding acyclic counterparts. Saturated derivatives showed slight reduction of potency compared to the respective unsaturated derivatives. Compound containing a 16-membered ...[more]

PMID: 25050776

Dataset Information

Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.

Publications

Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands.
| S-EPMC5647257 | biostudies-literature

Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation.
| S-EPMC6711809 | biostudies-literature

Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies.
| S-EPMC3800042 | biostudies-literature

Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
| S-EPMC3862176 | biostudies-literature

Design and synthesis of stereochemically defined novel spirocyclic P2-ligands for HIV-1 protease inhibitors.
| S-EPMC2745598 | biostudies-literature

Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
| S-EPMC7425579 | biostudies-literature

Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands.
| S-EPMC6237192 | biostudies-literature

Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities.
| S-EPMC7549267 | biostudies-literature

Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies.
| S-EPMC4765733 | biostudies-literature

Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.
| S-EPMC2797486 | biostudies-literature